Abstract:
"A Contribution to Clarify the Features of these New types of BORDERLINE's Personality becoming so numerous in the frame of our New Society with constant Evolution, without underestimating the usefulness of Assessment Scales in aiding diagnosis
About the presentation of diachronic observations, therefore also longitudinal, of patients encountered during on-call shifts in the C.H.R.U., of follow-ups during psychotherapeutic times developing over years or even in the context of forensic expertise, recalling that the assessment scales, however refined they may be, do not allow us to grasp all the psychopathological subtleties of these mosaic psychopathological entities, in order to refine the methods of care management in subjects with unstable relational exchange methods, psychotherapeutic follow-ups, which cannot be conceived as basic psychoanalyses, involving listening and interpretations but not demonstration of empathy. reassuring and soothing"
The epistemological and etiopathogenetic aspects need each time to be approach at their stem/roots
Biography:
Dr. Hugues Scharbach is a distinguished Neuropsychiatrist and National Expert (honorary) in pharmacotherapy, with an extensive background in clinical practice, academic teaching, and international research. He began his academic career as an assistant in neuroanatomy under Professor P. Delmas at the New Medical Faculty, Rue des Saints-Pères in Paris, and later served as an invited Professor of Physiology at the University of Bujumbura (1970–71) through the French Foreign Office. Upon returning to France, he held the position of Chef de Travaux Délégué in Physiology at the Paris 6 Faculty of Medicine. Clinically, he served as Psychiatre des Hôpitaux and led the Adult Psychiatry Service at Nantes CHRU before founding and directing the Child and Adolescent Psychiatry Service at the same hospital. Dr. Scharbach has taught extensively as Director of Clinical Psychiatry and has delivered lectures and presentations across France, Germany, Jordan, and Brazil. A Co-Keynote Speaker at the WHO Conference in Athens on Bipolar Spectrum Disorders (BSD), his contributions include significant publications such as the 1983 Congress Report of the Société de Psychiatrie et Neurologie de Langue Française in Poitiers. He has also been involved in advanced pharmacological research, notably on rubidium with Professor P.H. Loo, and has contributed to multiple Phase IV clinical trials.
